STAT

OCTOBER 12, 2023

Good morning, everyone, and welcome to another busy day. We are scrambling, in fact, to update our to-do list, schedule online calls, and sort out deadlines. To cope, we are quaffing several cups of stimulation, of course. Our choice today is maple bourbon. Meanwhile, here is the latest selection of interesting items for you to peruse.

255

255

STAT

JULY 31, 2024

These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.

Diabetes 363

Diabetes 363

STAT

JUNE 6, 2024

Federal officials, medical organizations, and reproductive health advocacy groups have expressed outrage in response to STAT’s recent investigation revealing that women with sickle cell disease have felt pressured into sterilizations as recently as 2017 and 2022.

361

361

STAT

SEPTEMBER 18, 2024

In 2017, at the age of 42, Susan Whitehead was diagnosed with an early form of breast cancer after discovering a lump in her breast. She embarked on a challenging path of treatment, including a recurrence with stage 2 cancer four years later. Susan underwent two lumpectomies, a mastectomy, radiation, and chemotherapy.

Chemotherapy 321

Chemotherapy 321

STAT

OCTOBER 10, 2024

Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017. He said then that he didn’t have children because of concerns he would pass on the disease to them. 

345

345

STAT

DECEMBER 4, 2023

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.  His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9 , which promised to cure numerous genetic diseases.

Documentation 363

Documentation 363

STAT

APRIL 3, 2024

That was until 2017, when he founded a startup called Nucleai. For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing satellite images. Now, he’s scouring biopsy samples for cancer cells. Nucleai’s technology is not searching out signs of danger.

347

347

STAT

MAY 21, 2024

She was seven months pregnant when the doctor brought it up in April 2017. She sat on the couch in the half-light, blinds shut against the heat. The whole thing made her feel less than, like some essential part of her had been removed. She shouldn’t eat before the operation.

364

364

STAT

MAY 24, 2023

Over the last few years, Daniel Cleggett Jr. appeared to be living a charmed life.

363

363

STAT

APRIL 23, 2024

But the agency noted in a press release that it’s the largest year-over-year update for NIH-funded postdocs since 2017. The 8% pay bump is far short of the increase to $70,000 that was recommended by an NIH working group late last year.

353

353

STAT

DECEMBER 8, 2023

In 2017, he was elevated to CEO. Samarth “Sam” Kulkarni has been there from almost the beginning. The former McKinsey partner joined CRISPR Therapeutics in 2015 as its chief business officer. STAT spoke to Kulkarni about how the company reached this point, and where the field of CRISPR-based medicine is going.

343

343

STAT

JULY 5, 2024

The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceutical company has spent on marketing to doctors since such data became available in 2017.

Pharmaceutical Companies 341

Pharmaceutical Companies Pharmaceutical Companies Hospitals 341

STAT

JUNE 17, 2024

From 2017 to 2020, the company sold nearly 8,000 devices with the fake component. Under CEO Laura Perryman’s leadership, the company warped the design of their devices to earn more reimbursement money from insurers, resulting in unnecessary plastic parts that allowed doctors to claim around $18,000 more than they previously could.

339

339

STAT

OCTOBER 19, 2023

Laronde was founded by biotech creation firm Flagship Pioneering in 2017 to develop a new type of genetic medicine called endless RNA. RNA medicines startup Laronde is merging with another startup in the wake of a scientific misconduct issue that affected its leading drug candidates.

350

350

STAT

JUNE 21, 2024

The employee, patient testing technician Qiqiuia Young, alleged in a 100-page lawsuit filed in 2017 that problems began when her co-workers at Stanford Cancer Center dressed as members of the Ku Klux Klan around Halloween.

Hospitals 347

Hospitals 347

STAT

MAY 6, 2024

Abrams, a frequent commentator about vaping in the news media, including CBS This Morning, CNN, and The New Yorker, coordinated extensively with Juul on public messaging in 2017 and 2018, according to company emails.

Documentation 363

Documentation 363

STAT

MAY 19, 2023

The company received the first FDA clearance for a standalone digital therapeutic in 2017 for reSET, a product that used cognitive behavioral therapy to treat substance use disorder. It was followed by clearances for reSET-O,  an app for opioid use disorder, and Somryst, for insomnia.

363

363

STAT

OCTOBER 10, 2024

The kickback case began four years ago when the Department of Justice accused Teva of using the foundations to ensure that, from 2006 through 2017, Medicare patients did not have to make a copayment or deductible for the Copaxone multiple sclerosis drug. At the same time, Teva steadily raised the price of its drug by thousands of dollars.

Pharmaceutical Companies 328

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 328

STAT

APRIL 5, 2023

are charged with knowingly selling defective lead testing machines between 2013 and 2017 that generated inaccurate results for tens of thousands of children across the country and for clients of at least one international relief organization, federal prosecutors said. Three former executives at Magellan Diagnostics Inc.

245

245

STAT

MARCH 5, 2024

The first continuous glucose monitor was approved by the FDA in 2017. The sensor will pair with a smartphone app, which will provide blood glucose measurements every 15 minutes. Dexcom has not yet released the price of the device.

Diabetes 361

Diabetes 361

STAT

APRIL 11, 2024

In 2017, after receiving reports about the telehealth site, an investigator for the California medical board logged on to Lemonaid using an alias. Ho Anh had just started working at Lemonaid Health when he was caught up in a sting.

347

347

STAT

MARCH 25, 2024

The initial effort to raise and sell chickens without using antibiotics began in 2017 as the company bet consumers would absorb the added expense. Continue to STAT+ to read the full story…

Labelling 345

Labelling 345

STAT

DECEMBER 30, 2022

If the recent acceleration of new diagnoses persists, then 220,000 people younger than 20 would have type 2 diabetes in 2060, compared with 28,000 in 2017, the latest year for which data is available, according to projections published this month in Diabetes Care. The number of young people in the U.S.

Diabetes 285

Diabetes 285

STAT

FEBRUARY 1, 2023

” But based on a final regulation published Monday, Medicare is going against that public interest by giving a free pass to Medicare Advantage plans for any erroneous codes they submitted between 2011 and 2017. The amount of taxpayer money that insurers will get to keep because of that decision: $2 billion.

285

285

STAT

FEBRUARY 29, 2024

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials.

Pharmaceutical Companies 353

Pharmaceutical Companies Pharmaceutical Companies Drug Development 353

STAT

DECEMBER 11, 2023

Boger, 72, founded Vertex in 1989 and served in various roles until 2017. Vertex Pharmaceuticals made history Friday when it received regulatory approval for a medicine that could alter people’s DNA. While the company celebrated, its founder, Joshua Boger, looked on like a proud parent.

Labelling 339

Labelling 339

STAT

APRIL 7, 2024

years after accelerated approval for cancer drugs to be pulled from the market if follow-up trials didn’t show a benefit; by 2017, that timing dropped to 3.6 The study also found evidence that drugs granted accelerated approval, meant to be a temporary designation, are spending less time in limbo. In 2013, it took an average of 9.9

363

363

STAT

AUGUST 16, 2023

Its trial was completed in 2017, but the company missed a deadline to seek a reporting extension. A  rule  went into effect in 2017 to strengthen reporting requirements. After receiving the FDA letter, Light Sciences posted results on Aug. 2, although outstanding issues remain with its submission.

246

246

STAT

JUNE 9, 2023

In 2017, the Massachusetts state Legislature passed a law to ensure ease of access to birth control. It says there should be no copay for hormonal birth control prescriptions. It also allows women to fill a 12-month prescription at once. Infertility care has similar protections.

297

297

STAT

APRIL 28, 2023

Smith was in STAT’s 2017 class of Wunderkinds , an annual selection of standout researchers who are launching their careers. Still, she knew from a very young age that she wanted to help people living with sickle cell disease. Now, as a research director at Vertex Pharmaceuticals, she is working on potential sickle cell medicines.

Medical Schools 297

Medical Schools Hospitals 297

STAT

JUNE 30, 2023

When I was diagnosed with breast cancer in 2017 and had bilateral mastectomies , I had more reconstruction options than my mother did. In 1983, I flew home from college to be with my mother as she woke up from a mastectomy. She opted out of breast reconstruction, choosing to “go flat” instead. Read the rest…

246

246

STAT

SEPTEMBER 3, 2024

These practices, which occurred between 2009 and 2017, allegedly harmed the country and patients. At the same time, the agency is examining accusations that the drug company disseminated “defamatory claims and news” in hopes of influencing physicians and consumers to favor its own treatment over competing medicines.

291

291

STAT

MARCH 26, 2024

By comparison, the FDA inspected 976 clinical study sites in 2017. In 2022, the health regulator inspected 537 hospitals and clinics that were conducting studies of medicines for which drug manufacturers were seeking approvals.

Hospitals 331

Hospitals 331

STAT

DECEMBER 20, 2023

From 2017 to 2020, the company implanted nearly 8,000 patients with these devices. Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could.

341

341

STAT

MAY 23, 2023

Overall estimated new infections dropped 12% in 2021 compared to 2017, according to data released Tuesday by the Centers for Disease Control and Prevention. The latest accounting of HIV incidence in the United States is a mixed bag. But the American South — which has had a longtime HIV problem compared with other areas across the U.S.

278

278

STAT

JULY 14, 2023

As North Carolina’s Secretary of Health and Human Services from January 2017 to December 2021, Cohen had a remarkably bipartisan record in a state with a fair share of partisan rancor. Read the rest…

246

246

STAT

SEPTEMBER 19, 2023

Pear’s reSET was the first such app cleared by the FDA in 2017. Pear, which filed for bankruptcy earlier this year , was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Continue to STAT+ to read the full story…

321

321